123 related articles for article (PubMed ID: 32129856)
21. Persistent infections in chronic Chagas' disease patients treated with anti-Trypanosoma cruzi nitroderivatives.
Braga MS; Lauria-Pires L; Argañaraz ER; Nascimento RJ; Teixeira AR
Rev Inst Med Trop Sao Paulo; 2000; 42(3):157-61. PubMed ID: 10887376
[TBL] [Abstract][Full Text] [Related]
22. Trypanosoma cruzi trans-sialidase: enhancement of virulence in a murine model of Chagas' disease.
Chuenkova M; Pereira ME
J Exp Med; 1995 May; 181(5):1693-703. PubMed ID: 7722448
[TBL] [Abstract][Full Text] [Related]
23. [The chemotherapy of Chagas disease].
Stoppani AO
Medicina (B Aires); 1999; 59 Suppl 2():147-65. PubMed ID: 10668258
[TBL] [Abstract][Full Text] [Related]
24. Identification of a new amide-containing thiazole as a drug candidate for treatment of Chagas' disease.
Álvarez G; Varela J; Cruces E; Fernández M; Gabay M; Leal SM; Escobar P; Sanabria L; Serna E; Torres S; Figueredo Thiel SJ; Yaluff G; Vera de Bilbao NI; Cerecetto H; González M
Antimicrob Agents Chemother; 2015 Mar; 59(3):1398-404. PubMed ID: 25512408
[TBL] [Abstract][Full Text] [Related]
25. Effects of immunosuppression and benzonidazole on Trypanosoma cruzi parasitism during experimental acute Chagas' disease.
Okumura M; Mester M; Iriya K; Amato Neto V; Gama-Rodrigues J
Transplant Proc; 1994 Jun; 26(3):1587-9. PubMed ID: 8030049
[No Abstract] [Full Text] [Related]
26. During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein.
Duthie MS; Wleklinski-Lee M; Smith S; Nakayama T; Taniguchi M; Kahn SJ
Infect Immun; 2002 Jan; 70(1):36-48. PubMed ID: 11748161
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of benznidazole treatment combined with nifurtimox, posaconazole or AmBisome® in mice infected with Trypanosoma cruzi strains.
Cencig S; Coltel N; Truyens C; Carlier Y
Int J Antimicrob Agents; 2012 Dec; 40(6):527-32. PubMed ID: 23063742
[TBL] [Abstract][Full Text] [Related]
28. Experimental benznidazole treatment of Trypanosoma cruzi II strains isolated from children of the Jequitinhonha Valley, Minas Gerais, Brazil, with Chagas disease.
Oliveira-Silva JC; Machado-de-Assis GF; Oliveira MT; Paiva NC; Araújo MS; Carneiro CM; Martins-Filho OA; Martins HR; Lana Md
Mem Inst Oswaldo Cruz; 2015 Feb; 110(1):86-94. PubMed ID: 25742267
[TBL] [Abstract][Full Text] [Related]
29. In vivo studies of 5-arylethenylbenzofuroxans in acute murine models of Chagas' disease.
Boiani L; Davies C; Arredondo C; Porcal W; Merlino A; Gerpe A; Boiani M; Pacheco JP; Basombrío MA; Cerecetto H; González M
Eur J Med Chem; 2008 Oct; 43(10):2229-37. PubMed ID: 18255195
[TBL] [Abstract][Full Text] [Related]
30. Comparison of PCR and microscopic methods for detecting Trypanosoma cruzi.
Kirchhoff LV; Votava JR; Ochs DE; Moser DR
J Clin Microbiol; 1996 May; 34(5):1171-5. PubMed ID: 8727897
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of the bisbenzylisoquinoline alkaloids in acute and chronic Trypanosoma cruzi murine model.
Fournet A; Rojas de Arias A; Ferreira ME; Nakayama H; Torres de Ortiz S; Schinini A; Samudio M; Vera de Bilbao N; Lavault M; Bonté F
Int J Antimicrob Agents; 2000 Jan; 13(3):189-95. PubMed ID: 10724023
[TBL] [Abstract][Full Text] [Related]
32. Organometallic Gold(III) Complex [Au(Hdamp)(L1
Lopes CD; Possato B; Gaspari APS; Oliveira RJ; Abram U; Almeida JPA; Rocho FDR; Leitão A; Montanari CA; Maia PIS; da Silva JS; de Albuquerque S; Carneiro ZA
ACS Infect Dis; 2019 Oct; 5(10):1698-1707. PubMed ID: 31419384
[TBL] [Abstract][Full Text] [Related]
33. In Vitro and In Vivo Trypanosomicidal Action of Novel Arylimidamides against Trypanosoma cruzi.
Guedes-da-Silva FH; Batista DG; Meuser MB; Demarque KC; Fulco TO; Araújo JS; Da Silva PB; Da Silva CF; Patrick DA; Bakunova SM; Bakunov SA; Tidwell RR; Oliveira GM; Britto C; Moreira OC; Soeiro MN
Antimicrob Agents Chemother; 2016 Apr; 60(4):2425-34. PubMed ID: 26856830
[TBL] [Abstract][Full Text] [Related]
34. Clomipramine and Benznidazole Act Synergistically and Ameliorate the Outcome of Experimental Chagas Disease.
García MC; Ponce NE; Sanmarco LM; Manzo RH; Jimenez-Kairuz AF; Aoki MP
Antimicrob Agents Chemother; 2016 Jun; 60(6):3700-8. PubMed ID: 27067322
[TBL] [Abstract][Full Text] [Related]
35. Indirubin derivatives are potent and selective anti-Trypanosoma cruzi agents.
Efstathiou A; Meira CS; Gaboriaud-Kolar N; Bastos TM; Rocha VPC; Vougogiannopoulou K; Skaltsounis AL; Smirlis D; Soares MBP
Virulence; 2018; 9(1):1658-1668. PubMed ID: 30387370
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo trypanocidal activity of some benzimidazole derivatives against two strains of Trypanosoma cruzi.
Díaz-Chiguer DL; Márquez-Navarro A; Nogueda-Torres B; de la Luz León-Ávila G; Pérez-Villanueva J; Hernández-Campos A; Castillo R; Ambrosio JR; Nieto-Meneses R; Yépez-Mulia L; Hernández-Luis F
Acta Trop; 2012 Apr; 122(1):108-12. PubMed ID: 22212465
[TBL] [Abstract][Full Text] [Related]
37. Effects of homeopathy in mice experimentally infected with Trypanosoma cruzi.
de Almeida LR; Campos MC; Herrera HM; Bonamin LV; da Fonseca AH
Homeopathy; 2008 Apr; 97(2):65-9. PubMed ID: 18439966
[TBL] [Abstract][Full Text] [Related]
38. In vivo activity of ursolic and oleanolic acids during the acute phase of Trypanosoma cruzi infection.
da Silva Ferreira D; Esperandim VR; Toldo MP; Kuehn CC; do Prado Júnior JC; Cunha WR; e Silva ML; de Albuquerque S
Exp Parasitol; 2013 Aug; 134(4):455-9. PubMed ID: 23648663
[TBL] [Abstract][Full Text] [Related]
39. Antitrypanosomal Activity of Sterol 14α-Demethylase (CYP51) Inhibitors VNI and VFV in the Swiss Mouse Models of Chagas Disease Induced by the Trypanosoma cruzi Y Strain.
Guedes-da-Silva FH; Batista DG; Da Silva CF; De Araújo JS; Pavão BP; Simões-Silva MR; Batista MM; Demarque KC; Moreira OC; Britto C; Lepesheva GI; Soeiro MN
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167559
[TBL] [Abstract][Full Text] [Related]
40. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
Braun M; de Titto E
Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
